Eloxx Pharmaceuticals (ELOX)
Develops ribosome-modulating medicines for nonsense-mutation kidney diseases.
$16.11
Pre-market+0.08 (+0.50%)
At close$16.03(+6.80%)
Something off on this page? Send us feedback.
Next report
Nov 11, 2026
in 69 days
EPS estimate
−$0.65
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Apr '23May '23Aug '23Nov '23Apr '25May '26Aug '26Nov '26
Reported−$32.12−$31.68−$21.56−$14.41−$4.95−$0.88−$0.66Pending
Estimate−$2.97−$2.55−$1.54−$1.97—−$6.40−$70.40−$0.65
Surprise−981.5%−1,142.4%−1,300.0%−631.5%—+86.3%+99.1%—
RevenueReportedEstimate
Apr '23May '23Aug '23Nov '23Apr '25May '26Aug '26Nov '26
Reported———————Pending
Estimate—$700.0K——————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.65 | — | — |
| Aug 2026 | −$70.40 | −$0.66 | +99.1% |
| May 2026 | −$6.40 | −$0.88 | +86.3% |
| Feb 2026 | −$6.40 | — | — |
| Apr 2025 | — | −$4.95 | — |
| Mar 2025 | — | — | — |
| Dec 2024 | $1.54 | — | — |
| Jun 2024 | −$4.50 | — | — |
| Jun 2024 | −$1.22 | — | — |
| Nov 2023 | −$1.97 | −$14.41 | −631.5% |
The latest year is open to everyone — the 36 quarters behind it read with an account. Sign in | |||
| Aug 2023 | |||
| May 2023 | |||
| Apr 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | — | — | — |
| Nov 2017 | — | — | — |
| Oct 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Oct 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Feb 2013 | — | — | — |
| Nov 2012 | — | — | — |
| Sep 2012 | — | — | — |
| May 2012 | — | — | — |
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 11, 2026 | −$0.65 | — | — | — | — | — | — |
| Aug 11, 2026 | −$70.40 | −$0.66 | +99.1% | — | — | — | −4.7% |
| May 5, 2026 | −$6.40 | −$0.88 | +86.3% | — | — | — | 0.0% |
| Feb 25, 2026 | −$6.40 | — | — | — | — | — | — |
| Apr 17, 2025 | — | −$4.95 | — | — | — | — | 0.0% |
| Mar 13, 2025 | — | — | — | — | — | — | — |
| Dec 16, 2024 | $1.54 | — | — | — | — | — | — |
| Jun 17, 2024 | −$4.50 | — | — | $1.8M | — | — | — |
| Jun 10, 2024 | −$1.22 | — | — | — | — | — | — |
| Nov 13, 2023 | −$1.97 | −$14.41 | −631.5% | — | — | — | −6.8% |
The latest year is open to everyone — the 36 quarters behind it read with an account. Sign in | |||||||
| Aug 14, 2023 | |||||||
| May 15, 2023 | |||||||
| Apr 3, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 15, 2022 | |||||||
| May 6, 2022 | |||||||
| Mar 31, 2022 | |||||||
| Nov 9, 2021 | |||||||
| Aug 16, 2021 | |||||||
| May 6, 2021 | |||||||
| Mar 11, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Aug 6, 2020 | |||||||
| May 7, 2020 | |||||||
| Mar 5, 2020 | |||||||
| Nov 5, 2019 | |||||||
| Aug 7, 2019 | |||||||
| May 9, 2019 | |||||||
| Mar 8, 2019 | |||||||
| Nov 8, 2018 | |||||||
| Aug 7, 2018 | |||||||
| May 10, 2018 | |||||||
| Mar 16, 2018 | — | — | — | — | — | — | — |
| Nov 14, 2017 | — | — | — | — | — | — | — |
| Oct 13, 2017 | |||||||
| May 22, 2017 | |||||||
| Feb 10, 2017 | |||||||
| Nov 16, 2016 | |||||||
| Oct 13, 2016 | |||||||
| May 12, 2016 | |||||||
| Feb 16, 2016 | |||||||
| Nov 16, 2015 | |||||||
| Feb 14, 2013 | — | — | — | — | — | — | — |
| Nov 14, 2012 | — | — | — | — | — | — | — |
| Sep 28, 2012 | — | — | — | — | — | — | — |
| May 14, 2012 | — | — | — | — | — | — | — |